Neuroleptic malignant syndrome in clinical practices
Topic: Neuroleptic Malignant Syndrome is a rare but specific lethal reaction to neuroleptics / antipsychotics.It occurs in 0.02% to 3.3% of patients in the treatment applying conventional neuroleptic drugs. Neuroleptic malignant syndrome is associated with highly potent antipsychotic drugs. However,...
Saved in:
Main Authors: | Bugarinović Snežana M. (Author), Đorđević Snežana S. (Author), Savić Olivera R. (Author), Mirjanić Tijana M. (Author) |
---|---|
Format: | Book |
Published: |
Srpsko lekarsko drustvo,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroleptic Malignant Syndrome and Methylphenidate
by: J Gordon Millichap
Published: (1998) -
Neuroleptic Malignant Syndrome Simulation Case
by: Jessica Brooks, et al.
Published: (2010) -
Neuroleptic malignant syndrome - a case report
by: Marcin Makuch, et al.
Published: (2019) -
Neuroleptic malignant syndrome - a case report
by: Marcin Makuch, et al.
Published: (2019) -
Neuroleptic malignant syndrome: A diagnostic challenge
by: Reshma P Ambulkar, et al.
Published: (2012)